AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $10,167,843 | -28.2% | 4,272,203 | -44.5% | 0.98% | -9.3% |
Q1 2023 | $14,152,936 | -4.3% | 7,691,813 | -1.2% | 1.08% | +13.2% |
Q4 2022 | $14,785,834 | +30.7% | 7,782,018 | +47.2% | 0.96% | +30.9% |
Q3 2022 | $11,312,000 | -22.3% | 5,286,088 | +2.8% | 0.73% | +0.3% |
Q2 2022 | $14,554,000 | -19.7% | 5,142,855 | +18.3% | 0.73% | -9.0% |
Q1 2022 | $18,124,000 | -14.4% | 4,346,327 | +6.6% | 0.80% | +7.7% |
Q4 2021 | $21,162,000 | +10.0% | 4,077,509 | +38.8% | 0.74% | +22.9% |
Q3 2021 | $19,236,000 | +61.5% | 2,936,791 | +63.7% | 0.61% | +79.3% |
Q2 2021 | $11,909,000 | – | 1,793,500 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |